display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HR positivebreast cancer - triple negative
la/mBC - HR positive - L2 - all populationmBC - Triple negative (TNBC) - (neo)adjuvant (NA)la/mBC - TNBC - L2 - all populationes-BC - TNBC - NA - all population
pegylated liposomal doxorubicin and cyclophosphamide ICON NSABP B-59/GBG 96-GeparDouze NSABP B-59/GBG 96-GeparDouze Alice IMpassion-031 ... IMpassion-031 ... ALEXANDRA/IMpassion-030

Study type: